SCHEMBL1127488

SCHEMBL1127488

CC1CCCC(N)N1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16897218 0.83 — —
SCHEMBL14607700 0.80 — —
SCHEMBL8302613 0.80 — —
SCHEMBL13014856 0.80 — —
SCHEMBL1776811 0.80 — —
SCHEMBL13014869 0.80 — —
Water SCHEMBL28596103 0.77 MGLL (0.44) —
SCHEMBL13069211 0.74 MGLL (0.40) —
SCHEMBL19667387 0.72 — —
SCHEMBL11610495 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109503462-B Synthesis method of tofacitinib intermediate (3R, 4R) -N, 4-dimethyl-1-benzyl-3-piperidylamine 内蒙古京东药业有限公司 2022-03-25 — — CN disclosed
EP-2282997-A2 4-METHYL-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXAMIDE USEFUL AS CANNABINOID CB1 NEUTRAL ANTAGONIST Laboratorios del Dr. Esteve S.A. (ES) 2011-02-16 — — EP disclosed
WO-2009124950-A2 4-METHYL-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXAMIDE USEFUL AS A CANNABINOID CB1 NEUTRAL ANTAGONIST LABORATORIOS DEL DR. ESTEVE, S. A. (ES) 2009-10-15 — — WO disclosed
Send feedback